» Articles » PMID: 15821888

Flow Cytometry Evaluation of the T-cell Receptor Vbeta Repertoire Among HIV-1 Infected Individuals Before and After Antiretroviral Therapy

Overview
Journal J Clin Immunol
Publisher Springer
Date 2005 Apr 12
PMID 15821888
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

HIV-1 infection leads to serious impairment of the immune system and perturbations in the T cell receptor Vbeta repertoire are also described. Immune reconstitution can be potentially achieved in response to HAART. In the present study 10 patients were investigated for the Vbeta pattern expression before and after six months of HAART. TCR were analyzed for T CD4+ and CD8+ subsets, separately, by flow cytometry, using a monoclonal antibody set of 24 different Vbeta chains. Compared to eight Brazilian healthy controls, no differences in Vbeta pattern of expression was observed for patients before or on antiretroviral therapy. Some chains such as Vbeta 3, 14, 16, 20 and 21.3 were over utilized by both T subsets, independently of HIV infection and/or antiretroviral treatment, differing from the ones described for individuals of other nationalities. However, when each patient was taken individually, particular alterations were detected for the Vbeta gene usage, compared to controls, for all individuals. After treatment, significant Vbeta usage changes were observed for seven patients. One or more chains on both T subsets were engaged in this process, defining a preferential oligoclonal profile for TCR repertoire distribution, after HAART. Although no pattern of specific Vbeta changes was detected in the circulating T cells, we cannot exclude that differential immune responses to HIV or other important antigens are being focused by these cells.

Citing Articles

Impaired Thymic Output Can Be Related to the Low Immune Reconstitution and T Cell Repertoire Disturbances in Relapsing Visceral Leishmaniasis Associated HIV/AIDS Patients.

Silva-Freitas M, Correa-Castro G, Cota G, Giacoia-Gripp C, Rabello A, Teixeira Dutra J Front Immunol. 2020; 11:953.

PMID: 32508833 PMC: 7251171. DOI: 10.3389/fimmu.2020.00953.


IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection.

Younes S, Freeman M, Mudd J, Shive C, Reynaldi A, Panigrahi S J Clin Invest. 2016; 126(7):2745-56.

PMID: 27322062 PMC: 4922693. DOI: 10.1172/JCI85996.


T-cell receptor Vβ repertoire of CD8+ T-lymphocyte subpopulations in cutaneous leishmaniasis patients from the state of Rio de Janeiro, Brazil.

Ferraz R, Cunha C, Pimentel M, Lyra M, Schubach A, de Mendonca S Mem Inst Oswaldo Cruz. 2015; 110(5):596-605.

PMID: 26107186 PMC: 4569821. DOI: 10.1590/0074-02760150039.


CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis.

Keesen T, Antonelli L, Faria D, Guimaraes L, Bacellar O, Carvalho E Clin Exp Immunol. 2011; 165(3):338-51.

PMID: 21726211 PMC: 3170983. DOI: 10.1111/j.1365-2249.2011.04430.x.


Distribution and evolution of T-cell receptor Vbeta repertoire on peripheral blood lymphocytes of newborn infants of human immunodeficiency virus (HIV)-infected mothers: differential display on CD4 and CD8 T cells and effect of HIV infection.

Borkowsky W, Chen S, Belitskaya-Levy I Clin Vaccine Immunol. 2007; 14(9):1215-22.

PMID: 17652526 PMC: 2043316. DOI: 10.1128/CVI.00092-07.

References
1.
Bouscarat F, Levacher M, Landman R, Girard P, Saimot A, Brun-Vezinet F . Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy. AIDS. 1998; 12(11):1267-73. DOI: 10.1097/00002030-199811000-00007. View

2.
Shigematsu M, NAGAI S, Mikuniya T, Izumi T, Wigzell H, Eklund A . T cell receptor (TCR) V gene segment use in HLA-typed Japanese healthy subjects. Clin Exp Immunol. 1996; 103(1):149-54. PMC: 2200323. DOI: 10.1046/j.1365-2249.1996.d01-14.x. View

3.
Koup R, Safrit J, Cao Y, Andrews C, McLeod G, Borkowsky W . Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994; 68(7):4650-5. PMC: 236393. DOI: 10.1128/JVI.68.7.4650-4655.1994. View

4.
Collier A, Coombs R, Schoenfeld D, Bassett R, Timpone J, Baruch A . Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med. 1996; 334(16):1011-7. DOI: 10.1056/NEJM199604183341602. View

5.
Graziosi C, Soudeyns H, Rizzardi G, Bart P, Chapuis A, Pantaleo G . Immunopathogenesis of HIV infection. AIDS Res Hum Retroviruses. 1998; 14 Suppl 2:S135-42. View